Important safety information and common side effects Do not use Wegovy or Ozempic with other GLP-1 receptor agonist medications or any other products containing Semaglutide or Tirzepatide
Shed GLP-1 is designed for adults with obesity, metabolic syndrome, or type 2 diabetes, and for anyone who has struggled to achieve meaningful weight loss through lifestyle changes alone
Mounjaro Week 1-4 Starting dose Week 5 Onwards Maintenance option 4 Weeks From Last Dose Maintenance option 4 Weeks From Last Dose Maintenance option 4 Weeks From Last Dose Maintenance option 4 Weeks From Last Dose Maintenance dose Wegovy Week 1-4 Starting dose Week 5-8 Step-up dose Week 9-12 Step-up dose Week 13-16 Step-up dose Week 17 Onwards Maintenance dose 4 Weeks From Last Dose Pending market approval View our Mounjaro and Wegovy pages for more information and links to clinical trials
La pldora de Wegovy contiene 25 miligramos, frente a los 14 miligramos de Rybelsus
If heartburn persists beyond the adjustment phase or interferes with your meals and sleep, that's your signal to discuss omeprazole or alternative approaches with your provider
Our microdosing approach further minimizes potential side effects